No image available for this title

LITERATURE

Intrapulmonary concentrations of meropenem administered by continuous infusion in critically ill patients with nosocomial pneumonia: a randomized pharmacokinetic trial


Optimal antimicrobial drug exposure in the lung is required for successful treatment outcomes for
nosocomial pneumonia. Little is known about the intrapulmonary pharmacokinetics (PK) of meropenem when
administered by continuous infusion (CI). The aim of this study was to evaluate the PK of two dosages of
meropenem (3 g vs 6 g/day by CI) in the plasma and epithelial lining fluid (ELF) in critically ill patients with
nosocomial pneumonia.


Availability

Tripenem-011Available

Detail Information

Series Title
-
Call Number
-
Publisher : .,
Collation
-
Language
English
ISBN/ISSN
-
Classification
NONE
Content Type
-
Media Type
-
Carrier Type
-
Edition
-
Subject(s)
Specific Detail Info
Critical Care (2020) 24:55
Statement of Responsibility

Other version/related

No other version available


File Attachment



Information


RECORD DETAIL


Back To Previous